During the past decade, Neurology and Stroke Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology and Stroke Associates" #1 collaborator was "Mallinckrodt ARD Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Neurology and Stroke Associates" are "Idiopathic Parkinson Disease" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Neurology and Stroke Associates" in a lesser frequency.

Most popular intervention types in "Neurology and Stroke Associates" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "XADAGO (safinamide)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurology and Stroke Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Neurology and Stroke Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neurology and Stroke Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neurology and Stroke Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".